ENTRY       7422              CDS       T01001
NAME        VEGFA, MVCD1, VEGF, VPF
DEFINITION  (RefSeq) vascular endothelial growth factor A
ORTHOLOGY   K05448  vascular endothelial growth factor A
ORGANISM    hsa  Homo sapiens (human)
PATHWAY     hsa01521  EGFR tyrosine kinase inhibitor resistance
            hsa04010  MAPK signaling pathway
            hsa04014  Ras signaling pathway
            hsa04015  Rap1 signaling pathway
            hsa04066  HIF-1 signaling pathway
            hsa04151  PI3K-Akt signaling pathway
            hsa04370  VEGF signaling pathway
            hsa04510  Focal adhesion
            hsa04926  Relaxin signaling pathway
            hsa04933  AGE-RAGE signaling pathway in diabetic complications
            hsa05163  Human cytomegalovirus infection
            hsa05165  Human papillomavirus infection
            hsa05167  Kaposi sarcoma-associated herpesvirus infection
            hsa05200  Pathways in cancer
            hsa05205  Proteoglycans in cancer
            hsa05206  MicroRNAs in cancer
            hsa05211  Renal cell carcinoma
            hsa05212  Pancreatic cancer
            hsa05219  Bladder cancer
            hsa05323  Rheumatoid arthritis
            hsa05418  Fluid shear stress and atherosclerosis
NETWORK     N00079  HIF-1 signaling pathway
            N00080  Loss of VHL to HIF-1 signaling pathway
            N00081  Mutation-inactivated VHL to HIF-1 signaling pathway
            N00095  ERBB2-overexpression to EGF-Jak-STAT signaling pathway
            N00157  KSHV vGPCR to GNB/G-ERK signaling pathway
            N00179  KSHV K1 to PI3K-NFKB signaling pathway
DISEASE     H01456  Diabetic nephropathy
            H01457  Diabetic retinopathy
            H01459  Diabetic neuropathy
            H01529  Avascular necrosis of femoral head
            H01709  Glucocorticoid-induced osteonecrosis
DRUG_TARGET Aflibercept: D09574
            Aflibercept beta: D10819
            Bevacizumab: D06409
            Bevasiranib sodium: D08874
            Brolucizumab: D11083
            Navicixizumab: D11126
            Pegaptanib: D05386
            Ranibizumab: D05697
BRITE       KEGG Orthology (KO) [BR:hsa00001]
             09130 Environmental Information Processing
              09132 Signal transduction
               04014 Ras signaling pathway
                7422 (VEGFA)
               04015 Rap1 signaling pathway
                7422 (VEGFA)
               04010 MAPK signaling pathway
                7422 (VEGFA)
               04370 VEGF signaling pathway
                7422 (VEGFA)
               04066 HIF-1 signaling pathway
                7422 (VEGFA)
               04151 PI3K-Akt signaling pathway
                7422 (VEGFA)
             09140 Cellular Processes
              09144 Cellular community - eukaryotes
               04510 Focal adhesion
                7422 (VEGFA)
             09150 Organismal Systems
              09152 Endocrine system
               04926 Relaxin signaling pathway
                7422 (VEGFA)
             09160 Human Diseases
              09161 Cancers: Overview
               05200 Pathways in cancer
                7422 (VEGFA)
               05206 MicroRNAs in cancer
                7422 (VEGFA)
               05205 Proteoglycans in cancer
                7422 (VEGFA)
              09162 Cancers: Specific types
               05212 Pancreatic cancer
                7422 (VEGFA)
               05211 Renal cell carcinoma
                7422 (VEGFA)
               05219 Bladder cancer
                7422 (VEGFA)
              09163 Immune diseases
               05323 Rheumatoid arthritis
                7422 (VEGFA)
              09166 Cardiovascular diseases
               05418 Fluid shear stress and atherosclerosis
                7422 (VEGFA)
              09167 Endocrine and metabolic diseases
               04933 AGE-RAGE signaling pathway in diabetic complications
                7422 (VEGFA)
              09172 Infectious diseases: Viral
               05163 Human cytomegalovirus infection
                7422 (VEGFA)
               05167 Kaposi sarcoma-associated herpesvirus infection
                7422 (VEGFA)
               05165 Human papillomavirus infection
                7422 (VEGFA)
              09176 Drug resistance: Antineoplastic
               01521 EGFR tyrosine kinase inhibitor resistance
                7422 (VEGFA)
             09180 Brite Hierarchies
              09183 Protein families: signaling and cellular processes
               04052 Cytokines and growth factors [BR:hsa04052]
                7422 (VEGFA)
               00536 Glycosaminoglycan binding proteins [BR:hsa00536]
                7422 (VEGFA)
            Cytokines and growth factors [BR:hsa04052]
             Growth factors
              Growth factors (RTK binding)
               7422 (VEGFA)
            Glycosaminoglycan binding proteins [BR:hsa00536]
             Heparan sulfate/Haparin
              Growth factors/receptors
               7422 (VEGFA)
POSITION    6p21.1
MOTIF       Pfam: VEGF_C PDGF
DBLINKS     NCBI-GeneID: 7422
            NCBI-ProteinID: NP_001165094
            OMIM: 192240
            HGNC: 12680
            Ensembl: ENSG00000112715
            Vega: OTTHUMG00000014745
            Pharos: P15692(Tclin)
            UniProt: P15692 A0A024RD33
STRUCTURE   PDB: 1MKK 4GLN 4GLS 1FLT 4KZN 4QAF 3QTK 1VPP 2VPF 5DN2 5HHC
                 5HHD 1MJV 5O4E 1CZ8 1BJ1 3P9W 1MKG 1VPF 3S1K 3BDY 1TZH
                 5FV1 1QTY 4ZFF 2FJG 1TZI 3S1B 2FJH 4WPB 3V2A 5FV2 2QR0
                 5T89 1KMX 1KAT 1VGH 2VGH
AASEQ       232
            MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVD
            IFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEM
            SFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPG
            PHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR
NTSEQ       699
            atgaactttctgctgtcttgggtgcattggagccttgccttgctgctctacctccaccat
            gccaagtggtcccaggctgcacccatggcagaaggaggagggcagaatcatcacgaagtg
            gtgaagttcatggatgtctatcagcgcagctactgccatccaatcgagaccctggtggac
            atcttccaggagtaccctgatgagatcgagtacatcttcaagccatcctgtgtgcccctg
            atgcgatgcgggggctgctgcaatgacgagggcctggagtgtgtgcccactgaggagtcc
            aacatcaccatgcagattatgcggatcaaacctcaccaaggccagcacataggagagatg
            agcttcctacagcacaacaaatgtgaatgcagaccaaagaaagatagagcaagacaagaa
            aaaaaatcagttcgaggaaagggaaaggggcaaaaacgaaagcgcaagaaatcccggtat
            aagtcctggagcgtgtacgttggtgcccgctgctgtctaatgccctggagcctccctggc
            ccccatccctgtgggccttgctcagagcggagaaagcatttgtttgtacaagatccgcag
            acgtgtaaatgttcctgcaaaaacacagactcgcgttgcaaggcgaggcagcttgagtta
            aacgaacgtacttgcagatgtgacaagccgaggcggtga
///
